Dutasteride in the treatment of benign prostatic hyperplasia: an update / 中华男科学杂志
National Journal of Andrology
;
(12): 63-67, 2011.
Artigo
em Chinês
| WPRIM
| ID: wpr-266209
ABSTRACT
Benign prostatic hyperplasia (BPH) is a common disease in older men. At present, 5alpha reductase inhibitor-based medication, preferred by most BPH patients as the first-choice therapy, is taking place of traditional transurethral resection of the prostate. This article presents an update of the researches on the treatment of BPH with dutasteride--a novel 5 alpha-reductase inhibitor.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Hiperplasia Prostática
/
Azasteroides
/
Usos Terapêuticos
/
Tratamento Farmacológico
/
Inibidores de 5-alfa Redutase
/
Dutasterida
Limite:
Humanos
/
Masculino
Idioma:
Chinês
Revista:
National Journal of Andrology
Ano de publicação:
2011
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS